Uso de Oclacitinib para el tratamiento de dermatosis autoinmunes: reporte de un caso

Abstract

Autoimmune dermatoses represent a small percentage of dermatoses in canines and their treatment with therapies based on glucocorticoids and immunosuppressants usually present long-term adverse effects for patients. The present work seeks to present another treatment alternative based on the drug Oclacitinib for the treatment of autoimmune dermatoses, offering good results and with few to no adverse effects. A clinical case was used to exemplify the above and to add to the experiences of the use of Oclacitinib in the treatment of autoimmune dermatoses.